Patient Guide: A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 99 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05489705
Status: 🟢 Enrolling Now
Condition: Obstructive Hypertrophic Cardiomyopathy
Phase: Not Specified

Where You Can Participate

This study is available at 99 locations across the country.

Top locations include:
  • • Anchorage, Alaska
  • • Tucson, Arizona
  • • Little Rock, Arkansas
  • • And 96 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM) - Join Clinical Trial NCTNCT05489705

How to Join This Clinical Trial - NCTNCT05489705

Learn how to participate in this Not Specified trial studying an investigational therapy for Obstructive Hypertrophic Cardiomyopathy. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Obstructive Hypertrophic Cardiomyopathy. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Obstructive Hypertrophic Cardiomyopathy
Treatment Being Tested
Investigational treatment
Study Phase
Not Specified - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05489705 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 99 locations. Find a study site near you:

Clinical Research Site

Anchorage, Alaska 99508 - United States

Status: RECRUITING

Clinical Research Site

Tucson, Arizona 85704 - United States

Status: RECRUITING

Clinical Research Site

Little Rock, Arkansas 72205-7199 - United States

Status: RECRUITING

Clinical Research Site

La Jolla, California 92037 - United States

Status: RECRUITING

Clinical Research Site

Los Angeles, California 90033 - United States

Status: RECRUITING

Clinical Research Site

Palo Alto, California 94304 - United States

Status: RECRUITING

Clinical Research Site

San Francisco, California 94117 - United States

Status: RECRUITING

Clinical Research Site

Aurora, Colorado 48377 - United States

Status: RECRUITING

Clinical Research Site

Hartford, Connecticut 06106 - United States

Status: RECRUITING

Clinical Research Site

Washington D.C., District of Columbia 20010 - United States

Status: RECRUITING

And 89 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this Not Specified clinical trial for Obstructive Hypertrophic Cardiomyopathy:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships